ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+13.07%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$246M
AUM Growth
+$246M
(-20%)
Cap. Flow
-$65.7M
Cap. Flow
% of AUM
-26.67%
Top 10 Holdings %
Top 10 Hldgs %
67.39%
Holding
78
New
29
Increased
8
Reduced
16
Closed
23
Top Buys
| 1 |
Merck
MRK
|
$14M |
| 2 |
Centene
CNC
|
$13.8M |
| 3 |
Sabra Healthcare REIT
SBRA
|
$5.43M |
| 4 |
Cigna
CI
|
$5.16M |
| 5 |
Elevance Health
ELV
|
$4.96M |
Top Sells
| 1 |
Humana
HUM
|
$15.9M |
| 2 |
Takeda Pharmaceutical
TAK
|
$14.3M |
| 3 |
Qiagen
QGEN
|
$13.1M |
| 4 |
Eli Lilly
LLY
|
$12.4M |
| 5 |
Baxter International
BAX
|
$11.9M |
Sector Composition
| 1 | Healthcare | 73.98% |
| 2 | Real Estate | 2.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
McKesson
MCK
$85.9B
| – | – |
-16,168
| Closed | -$5.5M |
|